Linked Life Data

9663179

Source:http://linkedlifedata.com/resource/pubmed/id/9663179

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1998-7-30
pubmed:abstractText
To assess the effect of liver impairment on the pharmacokinetics of tolcapone and to derive appropriate dose recommendations for patients with this disease who are undergoing treatment for Parkinson's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0009-9236
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
646-54
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites.
pubmed:affiliation
Department of Research and Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland. karin.jorga@roche.com
pubmed:publicationType
Journal Article, Clinical Trial